Scholar Rock
Trade Scholar Rock 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SRRK
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
SRRK Key Statistics
Stock Snapshot
With a market cap of 7.29B, Scholar Rock(SRRK) trades at $51.89. The stock has a price-to-earnings ratio of -15.03.
Scholar Rock(SRRK) stock opened on 2026-08-11 at $52.51. The price climbed to — and dipped to —.
Scholar Rock(SRRK) shares are trading with a volume of 0, against a daily average of 1.1M.
In the last year, Scholar Rock(SRRK) shares hit a 52-week high of $58.49 and a 52-week low of $27.07.
In the last year, Scholar Rock(SRRK) shares hit a 52-week high of $58.49 and a 52-week low of $27.07.
SRRK News
...
Scholar Rock (SRRK) announced that the FDA review of the apitegromab biologics license application, or BLA, for the treatment of children and adults with spinal...
Scholar Rock (NASDAQ:SRRK) said its resubmitted biologics license application for apitegromab remains on track for a U.S. Food and Drug Administration decision...
Analyst ratings
100%
of 17 ratingsMore SRRK News
Andres Y. Maldonado, an analyst from H.C. Wainwright, reiterated the Buy rating on Scholar Rock Holding. The associated price target remains the same with $65.0...
Scholar Rock reported second-quarter 2026 results showing a net loss of US$109.9 million and a basic loss per share of US$0.84, alongside updates on its apitegr...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
“We are on the threshold of securing the world’s first ever regulatory approval of a myostatin inhibitor, which will also be the first ever muscle-targeted trea...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.